New technology for cervical cancer screening

International Journal of Gynecological Cancer

Volumn 22, Issue 9, 2012, Pages 1564-1569

  Gong, Jiao Mei ^a   Shen, Yong ^a   He, Yan Xia ^a   Lei, Dong Mei ^a   Zhang, Zhan ^a   Li, Xiao Fu ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cervical cancer; Cytology; Human papillomavirus; New technology; Screening

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOMATION, LABORATORY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84872308250     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318272e7e7     Document Type: Article

References (14)

1. Arbyn M, Walker A, Meijer CJ. HPV-based cervical cancer screening in China. Lancet Oncol. 2010;11:1112-1113.
2. Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675-2686.
3. Mendoza LP, Arbiza J, Paez M, et al. Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion. J Med Virol. 2011;83:1351-1357.
4. Papanicolaou GN, Traut HF. Commonwealth f. Diagnosis of Uterine Cancer by the Vaginal Smear. New York, NY: The Commonwealth Fund; 1943.
5. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132:810-819.
6. Kok MR, Boon ME. Consequences of neural network technology for cervical screening: increase in diagnostic consistency and positive scores. Cancer. 1996;78:112-117.
7. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
8. Davies P, Kornegay J, Iftner T. Current methods of testing for human papillomavirus. Best Pract Res Clin Obstet Gynaecol. 2001;15:677-700.
9. Registry FC. Cancer Incidence in Finland 2000 and 2001. Helsinki, Finland: Cancer Society of Finland; 2003.
10. Noorani HZ BA, Skidmore B, Stuart GCE. Liquid-based cytology and human papillomavirus testing in cervical cancer. Liquid-based Cytology and Human Papillomavirus Testing in Cervical Cancer. Technology Report No. 40. Ottawa, Canada: Canadian Coordinating Office for Health Techology Assessment; 2003.
11. Nieminen P, Hakama M, Viikki M, et al. Prospective and randomised public health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year. Int J Cancer. 2003;103:422-426.
12. Nieminen P, Vuorma S, Viikki M, et al. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. BJOG. 2004;111:842-848.
13. Duggan MA. Papnet-assisted, primary screening of cervico-vaginal smears. Eur J Gynaecol Oncol. 2000;21:35-42.
14. Wright TC Jr, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.